Mwanzo068270 • KRX
add
Celltrion Inc
Bei iliyotangulia
₩ 197,200.00
Bei za siku
₩ 200,000.00 - ₩ 207,000.00
Bei za mwaka
₩ 144,615.31 - ₩ 251,000.00
Thamani ya kampuni katika soko
47.60T KRW
Wastani wa hisa zilizouzwa
elfu 560.82
Uwiano wa bei na mapato
44.21
Mgao wa faida
0.36%
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (KRW) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 1.33T | 25.06% |
Matumizi ya uendeshaji wa biashara | 383.06B | 10.26% |
Mapato halisi | 528.43B | 123.30% |
Kiwango cha faida halisi | 39.73 | 78.56% |
Mapato kwa kila hisa | elfu 2.40 | 117.62% |
EBITDA | 537.36B | 95.28% |
Asilimia ya kodi ya mapato | -0.01% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (KRW) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 1.24T | 8.40% |
Jumla ya mali | 22.33T | 6.08% |
Jumla ya dhima | 4.98T | 43.37% |
Jumla ya hisa | 17.35T | — |
hisa zilizosalia | 218.61M | — |
Uwiano wa bei na thamani | 2.51 | — |
Faida inayotokana na mali | 5.42% | — |
Faida inayotokana mtaji | 5.77% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (KRW) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 528.43B | 123.30% |
Pesa kutokana na shughuli | 139.88B | -54.28% |
Pesa kutokana na uwekezaji | -629.48B | -520.17% |
Pesa kutokana na ufadhili | 754.75B | 429.67% |
Mabadiliko halisi ya pesa taslimu | 309.21B | 1,200.88% |
Mtiririko huru wa pesa | -160.53B | -362.61% |
Kuhusu
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Seo Jung-jin, its founder was awarded the 2021 EY World Entrepreneur Of The Year. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
2002
Tovuti
Wafanyakazi
1,074
